2026 Q2 Portfolio Activity
In 2026 Q2, Sanofi maintained a portfolio of 11 distinct positions. The fund also reduced its exposure to Agomab Therapeutics NV by 70.5%.
Position History
hover any row below to update
Loading…
Sanofi
AUM $534M
Total Positions
11
Quarter
2026 Q2
Top Holding
MGTX (30.9%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-11 of 11
Sanofi Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MGTX
MeiraGTx Holdin...
|
Healthcare | 30.86% | 31.44% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
12,197,737 | $164,791,427 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-07-28 | |||
|
INBX
Inhibrx Bioscie...
|
Healthcare | 20.54% | 23.17% |
#2
Prev: #2
|
6.5 |
—
|
no change | no change |
P
S
|
1,157,926 | $109,713,489 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-07-28 | |||
|
NVAX
Novavax
|
Healthcare | 12.14% | 16.67% |
#3
Prev: #3
|
6.0 |
—
|
no change | no change |
P
S
|
6,880,481 | $64,814,131 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-07-28 | |||
|
ANAB
AnaptysBio
|
Healthcare | 10.39% | 9.04% |
#4
Prev: #4
|
5.5 |
—
|
no change | no change |
P
S
|
821,917 | $55,479,398 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-07-28 | |||
|
N/A
Odyssey Therape...
|
|
Unknown | 6.98% | — |
#5
Prev: #—
|
6.8 |
—
|
1,991,918 | — |
NEW
|
1,991,918 | $37,268,786 | — | 13F Filing | 2026-06-30 | 2026-07-28 | ||
|
N/A
Agomab Therapeu...
|
|
Unknown | 6.76% | 8.69% |
#6
1
Prev: #5
|
3.7 |
—
|
no change | no change |
P
S
|
2,783,096 | $36,124,586 | — | 13F Filing | 2026-06-30 | 2026-07-28 | ||
|
MPLT
MapLight Therap...
|
Healthcare | 6.12% | 5.52% |
#7
1
Prev: #6
|
3.4 |
—
|
no change | no change |
P
S
|
912,041 | $32,687,549 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-07-28 | |||
|
N/A
First Tracks Bi...
|
|
Unknown | 3.10% | — |
#8
Prev: #—
|
4.7 |
—
|
821,917 | — |
NEW
|
821,917 | $16,536,970 | — | 13F Filing | 2026-06-30 | 2026-07-28 | ||
|
IMRX
Immuneering Cor...
|
Healthcare | 2.53% | 4.25% |
#9
2
Prev: #7
|
2.0 |
—
|
no change | no change |
P
S
|
2,708,559 | $13,515,709 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-07-28 | |||
|
QTTB
Q32 Bio Inc.
|
Healthcare | 0.58% | 0.47% |
#10
1
Prev: #9
|
1.2 |
—
|
no change | no change |
P
S
|
244,083 | $3,109,617 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-07-28 | |||
|
ELDN
Eledon
|
Healthcare | 0.00% | 0.75% |
Sold All 😨
(Was: #8) |
0.0 |
—
|
-814,980 | -100.0% |
CLOSED
|
— | $— | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-07-28 |
Showing 1-11 of 11 holdings